Clinical Trial Update: Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults [NA]

View source ↗

Summary

A clinical trial update describes testing ivarmacitinib for moderate-to-severe Atopic Dermatitis in adolescents and adults, with the study currently not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Ivarmacitinib

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Atopic Dermatitis (AD) | NA | Status: NOT_YET_RECRUITING